At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 15 enrolled
Drug / intervention
PF-04191834 +4 moredrug
Likely dose
PF-04191834 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 2a, Randomised, Double-Blind (3rd Party Open), Double-Dummy, Placebo And Active Controlled 5-Way Crossover Study To Assess The Bronchodilatory Action, Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-04191834 In Asthmatic Patients.
In Brief
A Phase 2 clinical trial evaluating PF-04191834, zileuton, and 1 other intervention for Asthma. Completed, enrolled 15 participants across 4 sites.
Detailed Summary
Study to determine the bronchodilatory effects of PF-04191834 compared with zileuton in patients with asthma
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedJul 2008
Primary CompletionDec 2008
Study CompletionJul 2009
TodayJul 2026
First PostedJul 28, 2008
Enrollment StartJul 1, 2008
Primary CompletionDec 1, 2008
Study CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 17.9 years ago
Interventions
PF-04191834drug
30mg PF-04191834, single dose, oral dispersion + 2 x placebo tablets.
PF-04191834drug
100mg PF-04191834, single dose, oral dispersion + 2 x placebo tablets, single dose.
PF-04191834drug
2000mg PF-04191834, single dose, oral dispersion + 2 x placebo tables, single dose
zileutondrug
1200mg, 2 x 600mg tablets, single dose + placebo oral dispersion, single dose.
Placebodrug
2 x placebo tablets + placebo oral dispersion, single dose.